Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-061014
Filing Date
2014-08-14
Accepted
2014-08-14 14:57:23
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a14-14218_110q.htm 10-Q 762432
2 EX-31.1 a14-14218_1ex31d1.htm EX-31.1 12848
3 EX-31.2 a14-14218_1ex31d2.htm EX-31.2 12480
4 EX-32.1 a14-14218_1ex32d1.htm EX-32.1 7037
5 EX-32.2 a14-14218_1ex32d2.htm EX-32.2 6348
  Complete submission text file 0001104659-14-061014.txt   5181365

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT eglt-20140630.xml EX-101.INS 448147
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eglt-20140630.xsd EX-101.SCH 58416
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eglt-20140630_cal.xml EX-101.CAL 40971
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eglt-20140630_def.xml EX-101.DEF 323473
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT eglt-20140630_lab.xml EX-101.LAB 943853
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eglt-20140630_pre.xml EX-101.PRE 451448
Mailing Address 460 EAST SWEDESFORD ROAD SUITE 1050 WAYNE PA 19087
Business Address 460 EAST SWEDESFORD ROAD SUITE 1050 WAYNE PA 19087 610-833-4200
Egalet Corp (Filer) CIK: 0001586105 (see all company filings)

EIN.: 463575334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36295 | Film No.: 141041974
SIC: 2834 Pharmaceutical Preparations